Regulation of myeloid growth and differentiation by the insulin-like growth factor I receptor

Endocrinology

Volumn 138, Issue 1, 1997, Pages 362-368

  Li, Yong Ming ^a,b   Schacher, Daniel H ^a   Liu, Qiang ^a   Arkins, Sean ^a,c   Rebeiz, Natalie ^a,c   Mccusker Jr , Robert H ^a   Dantzer, Robert ^d   Kelley, Keith W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

^c ILLINOIS STATE UNIVERSITY   (United States)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; SOMATOMEDIN C RECEPTOR;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN HL 60; CELL VIABILITY; DATA ANALYSIS; DNA SYNTHESIS; FLOW CYTOMETRY; HORMONAL REGULATION; HUMAN; HUMAN CELL; HYPOTHESIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TISSUE CULTURE;

EID: 0642381066     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.1.4847     Document Type: Article

References (45)

1. Weigent DA, Blalock JE 1995 Associations between the neuroendocrine and immune systems. J Leukocyte Biol 58:137-150
2. Minshall C, Liu Q, Arkins S, Kelley KW 1996 Growth hormone and immunology. In: Torosian MH (ed) Growth Hormone in Critical Illness-Research and Clinical Studies. Landes, Austin, pp 161-186
3. Arkins S, Rebeiz N, Brunke-Reese DL, Minshall C, Kelley KW 1995 The colony-stimulating factors induce expression of insulin-like growth factor-I messenger ribonucleic acid during hematopoiesis. Endocrinology 136:1153-1160
4. Minshall C, Arkins S, Freund GG, Kelley KW 1996 Requirement for phosphotidylinositol 3′-kinase to protect hematopoietic progenitors against apoptosis depends upon the extracellular survival factor. J Immunol 156:939-947
5. LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT 1995 Molecular and cellular aspects of the insulin-like growth factor-I receptor. Endocr Rev 16:143-163
6. Kooijman R, Hooghe-Peters EL, Hooghe R 1996 Prolactin, growth hormone and insulin-like growth factor-I in the immune system. Adv Immunol 63:000-000
7. Baserga R 1994 Oncogenes and the strategy of growth factors. Cell 79:927-930
8. Porcu P, Ferber A, Pietrzkowski Z, Roberts CT, Adamo M, LeRoith D, Baserga R 1992 The growth stimulatory effect of simian virus 40 T antigen requires the interaction of insulin-like growth factor-I with its receptor. Mol Cell Biol 12:5069-5077
9. Porcu P, Graña X, Li S, Swantek J, De Luca A, Giordano A, Baserga R 1994 An E2F binding sequence negatively regulates the response of the insulin-like growth factor I (IGF-I) promoter to simian virus 40T antigen and to serum. Oncogene 9:2125-2134
10. Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A, Baserga R 1993 Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-I insulin-like growth factor receptor. Proc Natl Acad Sci USA 90:11217-11221
11. Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, Rubin R 1994 Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-I (IGF-I) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res 54:2218-2222
12. cdc2. Cancer Res 54:5531-5534
13. Daughaday WH 1990 The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 127:1-4 (Editorial)
14. Arkins S, Rebeiz N, Biragyn A, Reese DL, Kelley KW 1993 Murine macrophages express abundant IGF-I class I, Ea and Eb transcripts. Endocrinology 133:2334-2343
15. Gjerset RA, Yeargin J, Volkman SK, Vila V, Arya J, Haas M 1990 Insulin-like growth factor-I supports proliferation of autocrine thymic lymphoma cells with a pre-T cell phenotype. J Immunol 145:3497-3501
16. Landreth KS, Narayanan R, Dorshkind K 1992 Insulin-like growth factor-I regulates pro-B cell differentiation. Blood 80:1207-1212
17. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
18. Gibson LF, Piktel D, Landreth KS 1993 Insulin-like growth factor-I potentiates expansion of interleukin-7-dependent pro-B cells. Blood 82:3005-3011
19. Kimata H, Fujimoto M 1994 Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells. J Exp Med 180:727-732
20. Robbins K, McCabe S, Scheiner T, Strasser J, Clark R, Jardieu P 1994 Immunological effects of insulin-like growth factor-I-enhancement of immunoglobulin synthesis. Clin Exp Immunol 95:337-342
21. Nagaoka I, Trapnell BC, Crystal RG 1990 Regulation of insulin-like growth factor-I gene expression in the human macrophage-like cell line U-937. J Clin Invest 85:448-455
22. Li YM, Arkins S, McCusker RH Jr, Donovan SM, Liu Q, Jayaraman S, Dantzer R, Kelley KW 1996 Macrophages synthesize and secrete a 25-kilo-dalton protein that binds insulin-like growth factor-I. J Immunol 156:64-72
23. Forbes B, Szabo L, Baxter RC, Ballard FJ, Wallace JC 1988 Classification of the insulin-like growth factor binding proteins into three distinct categories according to their binding specificities. Biochem Biophys Res Commun 157:196-202
24. Clemmons DR, Dehoff ML, Busby WH, Bayne ML, Cascieri MA 1992 Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs. Endocrinology 131:890-895
25. Li YM, Brunke DL, Dantzer R, Kelley KW 1992 Pituitary epithelial cell implants reverse the accumulation of CD4 CD8 lymphocytes in thymus glands of aged rats. Endocrinology 130:2703-2709
26. Franklin RA, Li YM, Arkins S, Kelley KW 1990 Glutathione augments in vitro proliferative responses of lymphocytes to concanavalin A to a greater degree in old than in young rats. J Nutr 120:1710-1717
27. Harris P, Ralph P 1985 Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukocyte Biol 37:407-422
28. SAS Institute Inc 1989 SAS/STAT User's Guide, version 6, ed 4, vol 2. SAS Institute, Cary
29. Kooijman R, Scholtens LE, Rijkers GT, Zegers BJM 1995 Type I insulin-like growth factor receptor expression in different developmental stages of human thymocytes. J Endocrinol 147:203-209
30. Pepe MG, Ginzton NH, Lee PDK, Hintz RL, Greenberg PL 1987 Receptor binding and mitogenic effects of insulin and insulin-like growth factors I and II for human myeloid leukemia cells. J Cell Physiol 133:219-227
31. Baier TG, Jenne EW, Blum W, Schönberg D, Hartmann KKP 1992 Influence of antibodies against IGF-I, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines. Leukemia Res 16:807-814
32. Prager D, Li H-L, Asa S, Melmed S 1994 Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci USA 91:2181-2185
33. Neuenschwander S, Roberts Jr CT, LeRoith D 1995 Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor-I receptor antisense ribonucleic acid. Endocrinology 136:4298-4303
34. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Selzinger BR, Kley N 1995 Induction of the growth inhibitor IGF binding protein-3 by p53. Nature 377:646-649
35. Steele-Perkins G, Turner J, Edman JC, Hari J, Pierce SB, Stover C, Rutter WJ, Roth RA 1988 Expression and characterization of a functional human insulin-like growth factor-I receptor. J Biol Chem 263:11486-11492
36. Jonas HA, Cox AJ 1990 Insulin-like growth factor binding to the atypical insulin receptors of a human lymphoid-derived cell line (IM-9). Biochem J 266:737-742
37. Rutherford MS, Witsell A, Schook LB 1993 Mechanisms generating functionally heterogenous macrophages: chaos revisited. J Leukocyte Biol 53:602-618
38. Hirai K, Miyamasu M, Yamaguchi M, Nakajima K, Ohtoshi T, Koshino T, Takaishi T, Morita Y, Ito K 1993 Modulation of human basophil histamine release by insulin-like growth factors. J Immunol 150:1503-1508
39. Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (igf-i) and type I IGF receptor (ifg1r). Cell 75:59-72
40. Reiss K, Porcu P, Sell C, Pietrzkowski Z, Baserga R 1992 The insulin-like growth factor-I receptor is required for the proliferation of hemopoietic cells. Oncogene 7:2243-2248
41. Yateman ME, Claffey DC, Cwyfan Hughes SCC, Frost VJ, Wass JAH, Holly JMP 1993 Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production. J Endocrinol 137:151-159
42. Neely EK, Smith SD, Rosenfeld RG 1991 Human leukemic T and B lymphoblasts produce insulin-like growth factor binding proteins 2 and 4. Acta Endocrinol (Copenh) 124:707-714
43. Martin JL, Coverley JA, Pattison ST, Baxter RC 1995 Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol. Endocrinology 136:1219-1226
44. Arkins S, Rebeiz N, Brunke-Reese DL, Biragyn A, Kelley KW 1995 Interferon-γ inhibits macrophage insulin-like growth factor-I synthesis at the transciptional level. Mol Endocrinol 9:350-360
45. Lee W-H, Clemens JA, Bondy CA 1992 Insulin-like growth factors in the response to cerebral ischemia. Mol Cell Neurosci 3:36-43